117 related articles for article (PubMed ID: 37944525)
21. Development and validation of CYP26A1 inhibition assay for high-throughput screening.
Sakamuru S; Ma D; Pierro JD; Baker NC; Kleinstreuer N; Cali JJ; Knudsen TB; Xia M
Biotechnol J; 2024 Jun; 19(6):e2300659. PubMed ID: 38863121
[TBL] [Abstract][Full Text] [Related]
22. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer.
Kang JH; Jang JE; Mishra SK; Lee HJ; Nho CW; Shin D; Jin M; Kim MK; Choi C; Oh SH
J Ethnopharmacol; 2015 Sep; 173():303-12. PubMed ID: 26210065
[TBL] [Abstract][Full Text] [Related]
23. CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation.
Zhang Y; Wang S; Kang W; Liu C; Dong Y; Ren F; Wang Y; Zhang J; Wang G; To KF; Zhang X; Sung JJ; Chang Z; Yu J
Oncogene; 2018 Jun; 37(26):3485-3500. PubMed ID: 29563608
[TBL] [Abstract][Full Text] [Related]
24. USP7 Is a Tumor-Specific WNT Activator for APC-Mutated Colorectal Cancer by Mediating β-Catenin Deubiquitination.
Novellasdemunt L; Foglizzo V; Cuadrado L; Antas P; Kucharska A; Encheva V; Snijders AP; Li VSW
Cell Rep; 2017 Oct; 21(3):612-627. PubMed ID: 29045831
[TBL] [Abstract][Full Text] [Related]
25. The Synthetic Small Molecule FL3 Combats Intestinal Tumorigenesis via Axin1-Mediated Inhibition of Wnt/β-Catenin Signaling.
Jackson DN; Alula KM; Delgado-Deida Y; Tabti R; Turner K; Wang X; Venuprasad K; Souza RF; Désaubry L; Theiss AL
Cancer Res; 2020 Sep; 80(17):3519-3529. PubMed ID: 32665357
[TBL] [Abstract][Full Text] [Related]
26. Portulaca oleracea extract reduces gut microbiota imbalance and inhibits colorectal cancer progression via inactivation of the Wnt/β-catenin signaling pathway.
Yi S; Jin X; Liu B; Wu P; Xiao W; Chen W
Phytomedicine; 2022 Oct; 105():154279. PubMed ID: 35963192
[TBL] [Abstract][Full Text] [Related]
27. TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation.
Wu H; Lu XX; Wang JR; Yang TY; Li XM; He XS; Li Y; Ye WL; Wu Y; Gan WJ; Guo PD; Li JM
Autophagy; 2019 Sep; 15(9):1506-1522. PubMed ID: 30806153
[TBL] [Abstract][Full Text] [Related]
28. miR-370-3p Alleviates Ulcerative Colitis-Related Colorectal Cancer in Mice Through Inhibiting the Inflammatory Response and Epithelial-Mesenchymal Transition.
Lin L; Wang D; Qu S; Zhao H; Lin Y
Drug Des Devel Ther; 2020; 14():1127-1141. PubMed ID: 32214798
[TBL] [Abstract][Full Text] [Related]
29. Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/β-catenin signaling.
Peng K; Su G; Ji J; Yang X; Miao M; Mo P; Li M; Xu J; Li W; Yu C
J Biol Chem; 2018 Jul; 293(27):10606-10619. PubMed ID: 29802196
[TBL] [Abstract][Full Text] [Related]
30. The oncogenic function of PLAGL2 is mediated via ASCL2 and IGF2 and a Wnt-independent mechanism in colorectal cancer.
Fischer AD; Veronese Paniagua DA; Swaminathan S; Kashima H; Rubin DC; Madison BB
Am J Physiol Gastrointest Liver Physiol; 2023 Aug; 325(2):G196-G211. PubMed ID: 37310750
[TBL] [Abstract][Full Text] [Related]
31. Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells.
Ozpolat B; Mehta K; Lopez-Berestein G
Leuk Lymphoma; 2005 Oct; 46(10):1497-506. PubMed ID: 16194896
[TBL] [Abstract][Full Text] [Related]
32. Farnesoid X receptor antagonizes Wnt/β-catenin signaling in colorectal tumorigenesis.
Yu J; Li S; Guo J; Xu Z; Zheng J; Sun X
Cell Death Dis; 2020 Aug; 11(8):640. PubMed ID: 32807788
[TBL] [Abstract][Full Text] [Related]
33. mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer.
Mashima T; Taneda Y; Jang MK; Mizutani A; Muramatsu Y; Yoshida H; Sato A; Tanaka N; Sugimoto Y; Seimiya H
Oncotarget; 2017 Jul; 8(29):47902-47915. PubMed ID: 28615517
[TBL] [Abstract][Full Text] [Related]
34. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
35.
Facey COB; Hunsu VO; Zhang C; Osmond B; Opdenaker LM; Boman BM
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254755
[No Abstract] [Full Text] [Related]
36. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
Cheng X; Xu X; Chen D; Zhao F; Wang W
Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
[TBL] [Abstract][Full Text] [Related]
37. CRABPs Alter
Yabut KCB; Isoherranen N
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565751
[TBL] [Abstract][Full Text] [Related]
38. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer.
Li Q; Lai Q; He C; Fang Y; Yan Q; Zhang Y; Wang X; Gu C; Wang Y; Ye L; Han L; Lin X; Chen J; Cai J; Li A; Liu S
J Exp Clin Cancer Res; 2019 Aug; 38(1):334. PubMed ID: 31370857
[TBL] [Abstract][Full Text] [Related]
39. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C
J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010
[TBL] [Abstract][Full Text] [Related]
40. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
